3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 3 of 3 clinical reviews.
Evidence-based review of how CYP2C19 and CYP3A4 polymorphisms in Hispanic and Latino populations affect zolpidem metabolism, efficacy, and recommended dosing adjustments.
Evidence-based guide to zolpidem pharmacogenomic differences in East Asian populations, including CYP enzyme variants, dosing adjustments, and clinical monitoring considerations.
South Asian patients may need lower zolpidem (Ambien) doses due to CYP2C19 polymorphisms, lower BMI thresholds, and population-specific pharmacokinetics. This clinical guide covers dose adjustments, safety signals, and the evidence behind them.